BioCentury
ARTICLE | Financial News

Trevi raises $10M in A round

December 19, 2012 2:15 AM UTC

Trevi Therapeutics Inc. (New Haven, Conn.) raised $10 million in a series A round from existing investor TPG Biotech. Next half, Trevi plans to start Phase I testing of T111 in patients with hemodialy...